Tag: PR006

Lilly wraps up acquisition of gene therapy company Prevail Therapeutics

pharmanewsdaily- January 23, 2021

Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US ... Read More